Literature DB >> 28434080

Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.

Kyohei Ariake1, Fuyuhiko Motoi2, Hideo Ohtsuka2, Koji Fukase2, Kunihiro Masuda2, Masamichi Mizuma2, Hiroki Hayashi2, Kei Nakagawa2, Takanori Morikawa2, Shimpei Maeda2, Tatsuyuki Takadate2, Takeshi Naitoh2, Shinichi Egawa3, Michiaki Unno2.   

Abstract

PURPOSE: To evaluate the risk factors for peritoneal recurrence (PR) of pancreatic adenocarcinoma and to discuss the appropriate management strategies.
METHODS: We reviewed the medical records of 236 patients who underwent pancreatectomy for pancreatic adenocarcinoma. We then compared the clinicopathological characteristics of patients with vs. those without PR. The independent risk factors for PR were defined using the Cox proportional hazards regression model.
RESULTS: The median survival of patients with PR was 13.3 months after surgical treatment. The PR group had a significantly higher incidence of portal vein resection, longer operative time (≥648 min), greater blood loss (≥2179 mL), blood transfusion, tumor size, portal vein invasion, artery invasion, pancreatic nerve plexus invasion, and histological grade. Multivariate analysis revealed that excessive blood loss (≥2179 mL; P = 0.010), artery invasion (P = 0.025), pancreatic nerve plexus invasion (P = 0.001), and histological grade 3 (P = 0.011) were independent risk factors for PR. Excessive blood loss was also strongly related to tumor size (P = 0.018).
CONCLUSIONS: Local invasion and tumor size-related factors suggested the possibility of intraoperative dissemination at the time of tumor resection. Preoperative treatment and an operative procedure to prevent tumor exposure may help prevent PR.

Entities:  

Keywords:  Locally advanced pancreatic cancer; Pancreatic cancer; Peritoneal recurrence

Mesh:

Year:  2017        PMID: 28434080     DOI: 10.1007/s00595-017-1531-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

1.  Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings.

Authors:  Shoichi Hishinuma; Yoshiro Ogata; Moriaki Tomikawa; Iwao Ozawa; Kaoru Hirabayashi; Seiji Igarashi
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

2.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

3.  A novel preoperative predictor of pancreatic fistula using computed tomography after distal pancreatectomy with staple closure.

Authors:  Yasunari Fukuda; Daisaku Yamada; Hidetoshi Eguchi; Yoshifumi Iwagami; Takehiro Noda; Tadafumi Asaoka; Hiroshi Wada; Koichi Kawamoto; Kunihito Gotoh; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2017-03-06       Impact factor: 2.549

4.  Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas.

Authors:  Shunji Nagai; Tsutomu Fujii; Yasuhiro Kodera; Mitsuro Kanda; Tevfik T Sahin; Akiyuki Kanzaki; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
Journal:  Pancreas       Date:  2011-01       Impact factor: 3.327

5.  Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.

Authors:  Paolo Massucco; Lorenzo Capussotti; Antonella Magnino; Elisa Sperti; Marco Gatti; Andrea Muratore; Enrico Sgotto; Pietro Gabriele; Massimo Aglietta
Journal:  Ann Surg Oncol       Date:  2006-09-06       Impact factor: 5.344

6.  Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy.

Authors:  Tomohiro Arita; Daisuke Ichikawa; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Hidekazu Hiramoto; Junichi Hamada; Katsutoshi Shoda; Tsutomu Kawaguchi; Shoji Hirajima; Hiroaki Nagata; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Ann Surg Oncol       Date:  2014-09-09       Impact factor: 5.344

7.  Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.

Authors:  Hideki Ueno; Masafumi Ikeda; Makoto Ueno; Nobumasa Mizuno; Tatsuya Ioka; Yasushi Omuro; Takako Eguchi Nakajima; Junji Furuse
Journal:  Cancer Chemother Pharmacol       Date:  2016-02-03       Impact factor: 3.333

8.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

Authors:  Daniel D Von Hoff; Thomas Ervin; Francis P Arena; E Gabriela Chiorean; Jeffrey Infante; Malcolm Moore; Thomas Seay; Sergei A Tjulandin; Wen Wee Ma; Mansoor N Saleh; Marion Harris; Michele Reni; Scot Dowden; Daniel Laheru; Nathan Bahary; Ramesh K Ramanathan; Josep Tabernero; Manuel Hidalgo; David Goldstein; Eric Van Cutsem; Xinyu Wei; Jose Iglesias; Markus F Renschler
Journal:  N Engl J Med       Date:  2013-10-16       Impact factor: 91.245

9.  Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system.

Authors:  Matthew M Rochefort; Jacob S Ankeny; Brian E Kadera; Graham W Donald; William Isacoff; Zev A Wainberg; O Joe Hines; Timothy R Donahue; Howard A Reber; James S Tomlinson
Journal:  Ann Surg Oncol       Date:  2013-08-14       Impact factor: 5.344

10.  Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.

Authors:  Takuji Okusaka; Masafumi Ikeda; Akira Fukutomi; Tatsuya Ioka; Junji Furuse; Shinichi Ohkawa; Hiroyuki Isayama; Narikazu Boku
Journal:  Cancer Sci       Date:  2014-09-29       Impact factor: 6.716

View more
  6 in total

1.  Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms: A Single-Center Retrospective Study.

Authors:  Koki Hayashi; Yoshihiro Ono; Manabu Takamatsu; Atsushi Oba; Hiromichi Ito; Takafumi Sato; Yosuke Inoue; Akio Saiura; Yu Takahashi
Journal:  Ann Surg Oncol       Date:  2022-03-01       Impact factor: 5.344

2.  18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Kyohei Ariake; Fuyuhiko Motoi; Hideo Shimomura; Masamichi Mizuma; Shimpei Maeda; Chiaki Terao; Yasuko Tatewaki; Hideo Ohtsuka; Koji Fukase; Kunihiro Masuda; Hiroki Hayashi; Tatsuyuki Takadate; Takeshi Naitoh; Yasuyuki Taki; Michiaki Unno
Journal:  J Gastrointest Surg       Date:  2017-11-08       Impact factor: 3.452

3.  A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model.

Authors:  Hidenori Ando; Masakazu Fukushima; Kiyoshi Eshima; Taichi Hasui; Taro Shimizu; Yu Ishima; Cheng-Long Huang; Hiromi Wada; Tatsuhiro Ishida
Journal:  Cancer Med       Date:  2019-10-14       Impact factor: 4.452

4.  Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer.

Authors:  Dang Chao; Kyohei Ariake; Satoko Sato; Hideo Ohtsuka; Tatsuyuki Takadate; Masaharu Ishida; Kunihiro Masuda; Shimpei Maeda; Takayuki Miura; Katsutaka Mitachi; Xun Jing Yu; Fumiyoshi Fujishima; Masamichi Mizuma; Kei Nakagawa; Takanori Morikawa; Takashi Kamei; Michiaki Unno
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

5.  Recurrence and Prognostic Value of Circulating Tumor Cells in Resectable Pancreatic Head Cancer: A Single Center Retrospective Study.

Authors:  Qiao Zhang; Feng Xia; Qiang Sun; Wenjing Cao; Ali Mo; Weiming He; Jiazhen Chen; Weiqiao Zhang; Weiqiang Chen
Journal:  Front Surg       Date:  2022-04-06

6.  Analysis of lncRNA-mRNA networks after MEK1/2 inhibition based on WGCNA in pancreatic ductal adenocarcinoma.

Authors:  Jing Qian; Jianxin Yang; Xianchen Liu; Zhiming Chen; Xiaodi Yan; Hongmei Gu; Qiang Xue; Xingqin Zhou; Ling Gai; Pengpeng Lu; Yu Shi; Ninghua Yao
Journal:  J Cell Physiol       Date:  2019-10-03       Impact factor: 6.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.